TOXYLACT: a02aa magnesium antiacids
The first professional lActological database in the word
Magnesium-containing antacids are widely used to neutralize gastric acid by binding hydrogen ions in the gastric lumen, thereby reducing gastric acidity. They are indicated for the treatment of duodenal ulcer disease, acute gastritis and gastroesophageal reflux, and are also used as gastroprotective agents when drugs with gastrointestinal toxicity are co‑administered. The most common adverse effect of magnesium antacids is lower gastrointestinal dyspepsia, while allergic reactions are rare and largely anecdotal. According to our toxicological lactation classification, magnesium antacids used in standard therapeutic doses are considered compatible with breastfeeding and do not require interruption of lactation. The toxicological information on this site reflects the current state of knowledge at the time of publication and is regularly updated as new safety data become available.


